Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RNA nanomedicine in liver diseases

19 Sept 2023

Abstract excerpt

The remarkable impact of RNA nanomedicine during the COVID-19 pandemic has demonstrated the expansive therapeutic potential of this field in diverse disease contexts. In recent years, RNA nanomedicine targeting the liver has been paradigm-shifting in the management of metabolic diseases such as hyperoxaluria and amyloidosis. RNA nanomedicine has significant potential in the management of liver diseases, where...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to RNA modifications and cancer
Share to RNA regulation and disease
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37725757
DOI: 10.1097/hep.0000000000000606

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RNA nanomedicine in liver diseasesPMID 37725757Read ↗

Advances in RNA Therapeutics: Classes, Innovations and Clinical ApplicationsSemantic proximity Read ↗

mRNA and gene editing: Late breaking therapies in liver diseasesSemantic proximity Read ↗

RNA nanotherapeutics for hepatocellular carcinoma treatmentSemantic proximity Read ↗

Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver OriginSemantic proximity Read ↗

Messenger RNA therapy for rare genetic metabolic diseasesSemantic proximity Read ↗

Nanogene editing drug delivery systems in the treatment of liver fibrosisSemantic proximity Read ↗

Emerging mRNA Technology for Liver Disease TherapySemantic proximity Read ↗

Delivering the Message: Translating mRNA Therapy for Liver Inherited Metabolic DiseasesSemantic proximity Read ↗

Recent advances in nanoparticulate RNA delivery systemsSemantic proximity Read ↗

mRNA-Based Approaches to Treating Liver DiseasesSemantic proximity Read ↗

Lipid Nanoparticles for Spleen-Targeted RNA deliverySemantic proximity Read ↗

A read-through circular RNA RCRIN inhibits metabolic dysfunction-associated steatotic liver diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.